Results 231 to 240 of about 21,803,006 (294)
H2-O deficiency in B cells or dendritic cells drives retrovirus-neutralizing antibody responses. [PDF]
Dobkin J +4 more
europepmc +1 more source
In head and neck squamous cell carcinoma (HNSCC) p53 and p63 exert opposite roles on the transcription regulation of the lncRNA NEAT1. Under basal conditions, p53 levels are low and p63 represses NEAT1 expression. Upon genotoxic stress, p53 is rapidly induced, displacing p63 from the NEAT1 promoter leading to NEAT1 transcriptional activation and ...
Sara De Domenico +5 more
wiley +1 more source
Rosa26-INDIA Identifies Early Apoptotic B Cells Before Macrophage-Mediated Efferocytosis. [PDF]
Ansari UA, Wisniewski J, Mayer CT.
europepmc +1 more source
Isocitrate dehydrogenase 1 (IDH1) mutations are highly recurrent in multiple human cancer types, including cholangiocarcinoma and glioma. IDH1 R132C is the most common IDH1 mutation in cholangiocarcinoma and likely arises from APOBEC3A‐ or APOBEC3B‐mediated deamination.
Kelly E. Butler +3 more
wiley +1 more source
Metabolic Reprogramming of B Cells in Cancer: Effects of Altered Energetics. [PDF]
Sarkar UA +4 more
europepmc +1 more source
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault +12 more
wiley +1 more source
Regulatory B Cells in Tumor Microenvironment. [PDF]
Cai Z, Xie L.
europepmc +1 more source
Defining the rules of engagement: B cells, antibodies and cancer control. [PDF]
Nutt SL, Tellier J, Da Gama Duarte J.
europepmc +1 more source

